Jennifer Maier

Jennifer Maier has extensive work experience in various roles related to quality assurance, pharmacovigilance, and regulatory operations in the biopharmaceutical industry. Jennifer'scurrent role is Senior Director of GCP Quality Assurance at Day One Biopharmaceuticals. Prior to this, they worked as the Director of GCP Quality Assurance at Fulcrum Therapeutics. Jennifer also held positions at Alexion Pharmaceuticals, Biogen, Shire Pharmaceuticals, and EMD Serono, Inc. Jennifer'sroles during these years included managing audit activities, overseeing pharmacovigilance and clinical trial safety, and managing nursing support services. Jennifer started their career as a Registered Nurse at pediatric intensive care units in Riley Children's Hospital. Overall, Jennifer Maier has a diverse background in ensuring compliance and quality in the pharmaceutical industry.

Jennifer Maier attained a Master's degree in Regulatory Affairs Quality Assurance from Temple University School of Pharmacy from 2019 to 2022. Prior to that, they obtained a Bachelor's degree in Registered Nursing/Registered Nurse from Indiana University–Purdue University Indianapolis in 2003, and an Associate of Science (A.S.) in Registered Nursing/Registered Nurse from the same institution in 2001. Jennifer also attended Vincennes University from 1996 to 1999, but their degree and field of study are unspecified. Furthermore, they received training as a Medical/Clinical Assistant from Midwest Career College in 1993. In addition to their educational background, Jennifer has obtained certifications such as Certified Multiple Sclerosis RN from IOMSN and DIA Clinical Safety & Pharmacovigilance. Specific dates and institutions for these certifications are not provided.